Inhibition of vascular remodelling in a porcine coronary injury model by herbal extract XS0601 by Xu, Hao et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Chinese Medicine
Open Access Research
Inhibition of vascular remodelling in a porcine coronary injury 
model by herbal extract XS0601
Hao Xu*1, Dazhuo Shi2 and Keji Chen1,2
Address: 1National Integrative Medicine Centre for Cardiovascular Diseases, China-Japan Friendship Hospital, 2 Yinghuayuan East Street, 
Chaoyang District, Beijing 100029, China and 2Division of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medicial 
Sciences, 1 Xiyuan Caochang, Haidian District, Beijing 100091, China
Email: Hao Xu* - xuhao2005@yahoo.com.cn; Dazhuo Shi - heartmail@263.net; Keji Chen - chen.keji@gmail.com
* Corresponding author    
Abstract
Background: Arterial remodelling is a major pathologic change of restenosis after percutaneous
coronary intervention (PCI). Our previous studies showed that XS0601 (consisting of
Chuangxingol and paeoniflorin) had some effects on the prevention of restenosis after PCI.
Therefore, the purpose of this study was to examine whether and how its mechanism was related
to the regulation of the arterial remodelling after endothelial injury by balloon dilation.
Methods: Twenty Chinese mini-pigs were randomized into four groups: control, probucol, low-
dose XS0601 and high-dose XS0601 group before oversized balloon injury of the left anterior
descending coronary arteries. Starting from two days before balloon injury, the mini-pigs in the
treated group were administered with probucol (2 g/day) and XS0601 (0.02 g/kg/day for low dose;
0.04 g/kg/day for high dose) for four weeks after balloon injury. The animals receiving balloon injury
alone were used as control. Morphometric and angiographic analysis of the injured arteries were
performed.
Results: The contribution of intimal hyperplasia and arterial remodelling to angiographic late
lumen loss was 41% and 59% respectively. XS0601 markedly inhibited proliferation of smooth
muscle cells (SMCs) and transformation of SMCs from contractile to synthetic phenotype in
neointima, inhibited hyperplasia-related indices of morphometric analysis and reduce late
angiographic lumen loss. The reduction of the late angiographic lumen loss resulting from vascular
remodelling was greater after XS0601 treatment.
Conclusion: Both intimal hyperplasia and vascular remodelling are attributed to late lumen loss in
this porcine coronary injury model. XS0601 markedly reduced angiographic late lumen loss
resulting from intimal hyperplasia, vascular remodelling and XS0601 may be a potential agent to
prevent restenosis after PCI.
Background
Restenosis after percutaneous coronary intervention
(PCI), including percutaneous transluminal coronary
angioplasty (PTCA) and stenting, is a major factor affect-
ing the long-term success of PCI [1]. Despite numerous
trials of pharmacologic interventions, the frequency of
restenosis did not diminish [2]. The process of restenosis
is not fully understood. Nevertheless, intimal hyperplasia
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resulting from the proliferation of smooth muscle cells
(SMCs) and synthesis of extracellular matrix affect the
healing process of an injured artery and restenotic lesion
[2-5]. Recently, human and animal studies have shown
that vascular remodelling, the change of the total arterial
circumference (also called geometric remodelling), is a
response to arterial intervention and related to the forma-
tion of restenosis [6-8].
The porcine model for studying restenosis has specific
advantages over other animal models because of its simi-
larities to the human coronary circulation, particularly the
spontaneous development of atherosclerosis and the
response to vascular injury [9]. In a balloon injury model
of coronary restenosis in normolipemic swine, intimal
smooth muscle cell proliferation is histologically similar
to the hyperplasia in human restenosis [10]. XS0601 con-
sists of Chuangxingol and paeoniflorin, which are active
components of Ligusticum chuanxiong Hort and Paeonia
lactiflora Pall. Our previous study showed that XS0601
restrained the proliferation of cultured SMC stimulated by
endothelin (ET) [11]. The purpose of the present study is
to observe the effect of XS0601 on vascular remodelling in
a porcine coronary injury model and to determine
whether it will be a potential agent for preventing resten-
osis.
Methods
Animals and medications
Twenty Chinese mini-pigs weighing between 28 and 36 kg
were randomly assigned into four groups. Group 1 (Con-
trol) consisted of 5 untreated animals. Group 2 to group
4 each with 5 mini-pigs received different drugs beginning
2 days before balloon injury and continuing throughout
the 4-week study period. Group 2 (Probucol) received
probucol 2000 mg once a day. Group 3 received 0.02 g/kg
of low dose XS0601 (LXS). Group 4 was fed with 0.04 g/
kg of high dose XS0601 (HXS). The composition and
preparation of XS0601 was the same as previously
described [11]. The drugs were crushed to powder and
mixed with corn syrup. All animals were fed with normo-
lipemic diet. This study was in compliance with the guide-
lines of the National Institutes of Health and American
Heart Association for the care and use of animals.
Procedure of balloon injury
All animals were pre-medicated with 325 mg aspirin and
60 mg diltiazem HCl the day before the procedure. The
animals were sedated by intramuscular injection of a com-
bination of ketamine (25 mg/kg) and diazepam (1 mg/
kg). Half milligram of atropine was given intramuscularly
to limit mucous secretions. Anaesthesia was maintained
with 2.5% thiopental sodium by administering 2–3 ml
every hour. The trachea was intubated. The pigs were
allowed to breathe spontaneously unless ventilation
became depressed. Adequate anaesthesia was confirmed
by the absence of a limb withdrawal reflex or corneal
reflex. The ECG and intra-arterial blood pressure were
monitored throughout the procedure. Coronary artery
injury model was established according to a method
slightly modified from Schneider JE, et al. [12]. Over-
stretch-balloon injury was performed with a 20-mm-
length PTCA catheter; the inflated balloon-to-artery ratio
was about 1.4; the catheter was advanced to mid segment
of the left anterior descending coronary artery (LAD).
Three 30-second inflations were performed at 10 atm.
Between inflations there was one minute deflation period
for coronary perfusion. Uninstrumented left circumflex
coronary artery (LCx) was used as a control. The animals
were sacrificed at the fourth week after the initial over-
stretch injury, the heart was rapidly excised through a left
thoracotomy. The left main coronary artery was per-
fusion-fixed and serial 4 mm sections were then processed
and embedded in paraffin. Cross-sections (4 µm thick)
were stained with Verhoeff-van Gieson stains. Angiogra-
phy was taken at 45 left anterior oblique (LAO) before,
immediately after and 4 weeks after PTCA, and 45 right
anterior oblique (RAO) views were recorded on video
tape for later analysis.
Morphometric analysis
Each specimen was examined by an experienced cardio-
vascular pathologist blinded to the treatment group. A
lesion grading system based on the criteria [13] listed in
Table 1 and computerized color image analysis system
(Huizhong Company, China) was applied to morpho-
metric analysis of the narrowest site of the lesion segment.
The maximal intimal thickness (MIT, mm) was deter-
mined by distance between the internal elastic membrane
and the outermost layer of the neointima, circumference
of the internal elastic lamina (IELc, mm) and its fracture
length (IELf, mm). The extent of injury (injury score, IS)
was represented by the IELf, standardized for the size of
the artery and expressed by the IELc: IELf/IELc. Area meas-
urements were obtained by tracing the lumen, internal
elastic lamina (IEL) and external elastic lamina (EEL):
lumen area (LA, mm2), area delimited by the IEL (IELa,
mm2) and area delimited by the EEL (EELa, mm2). Thus,
media area (MA, mm2) obtained by subtracting IELa from
EELa, intima area (IA, mm2) generated by subtracting
lumen area from IELa. The residual lumen (RL) was
expressed by lumen area: LA/IELa. Proliferation index (PI)
was expressed by IA/EELa. To quantitatively assess the sep-
arate contributions of intimal hyperplasia and arterial
remodelling to angiographic late lumen loss, according to
the methods introduced by Post MJ et al. [6], we defined
some values as described below. The potential cross-sec-
tional lumen area was calculated from the perimeter of
the IEL, assuming a circular configuration. The actual
cross-sectional area was obtained by subtracting the areaChinese Medicine 2006, 1:2 http://www.cmjournal.org/content/1/1/2
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of intima from the potential lumen area. The difference
between the radius of potential and actual lumen, derived
from their respective cross-sectional areas, was taken as
the average thickness of neointima. Arterial remodelling
could be obtained by subtracting the doubled average
thickness of neointima from late lumen loss. The late
lumen loss could be examined by angiographic analysis.
The contribution of neointimal thickness or remodelling
to late lumen loss could be calculated by dividing late
lumen loss by neointimal thickness or remodelling.
Transmission electron microscopy
Tissue samples were fixed at 4°C in 2.5% glutaraldehyde,
post-fixed in 1% osmium tetroxyde, dehydrated and
embedded in Epon 812. The lesion (intima) was located
by semithin section. The slice was prepared by ultra-sec-
tioning, stained with uranyl acetate and lead citrate and
examined in a JEM-1200EX transmission electron micro-
scope (Japan). The morphologic criteria used for recogni-
tion of SMCs were the presence of basal lamina,
plasmalemmal vesicles, and myofilament bundles with
associated dense bodies. Only those cell profiles of suffi-
cient size to be characterized as SMCs by those criteria
were analyzed.
Immunocytochemical detection of proliferating SMCs
The proliferative profile of the intima was evaluated by
immunocytochemical detection of proliferating cell
nuclear antigen (PCNA), which is considered to be a valid
indicator of cell replication. Paraffin sections from coro-
nary arteries isolated 4 weeks after balloon injury were
dewaxed, rehydrated, and boiled for 2 × 5 minutes with
antigen retrieval buffer in a microwave oven. Endogenous
peroxidase was blocked for 10 minutes with 3% hydrogen
peroxide. Sections were incubated overnight with a mon-
oclonal anti-PCNA antibody (ZYMED Company, 1:100
dilution) at 4°C. A biotinylated rabbit anti-mouse sec-
ondary antibody was then applied at 37C for 30 minutes,
followed by streptavidin peroxidase at 37°C for 30 min.
Immunocytochemical detection was visualized with a
standard peroxidase enzyme substrate for 3 min. Sections
were counterstained with methyl green and mounted with
glycerol gelatine. The number of PCNA-positive nuclei
and the total number of nuclei within the intima were
counted, and proliferation was expressed as the PCNA-
labelling index [(number of PCNA-positive nuclei/total
number of nuclei) × 100%].
Angiographic analysis
Angiography analysis was performed by digital calipers on
the cinefilms obtained during the baseline study (initial
balloon injury) and follow-up study (when the animals
were sacrificed). Arterial diameters of the injury site were
measured before and after balloon dilations and the bal-
loon-to-artery ratio was calculated. Thus the acute gain
and late lumen loss was obtained. The minimum angio-
graphic lumen diameter was measured by an angiogra-
pher blinded to treatment groups. The arterial diameters
were corrected for angiographic magnification. The mag-
nification factor was determined by dividing the angio-
graphic balloon diameter by the ex vivo measured balloon
diameter.
Statistical analysis
Data were expressed as mean ± SD and analyzed by a one-
factor ANOVA with STATA 4.0 software. Differences were
considered significant at P < 0.05.
Results
The characteristics of these four groups are listed in Table
2. There was no significant difference in body weight at
the time of balloon injury. Rupture of IEL was seen in all
animals. The angiographic balloon-to-artery ratios, dila-
tion after injury, the pathologic grades and injury scores
based on morphometric analysis were similar among all
groups.
Morphometric analysis
There was rupture of the IEL with neointimal growth
replacing the disrupted media at 4 weeks after injury (Fig-
ure 1). Injury (rupture of IEL) was documented in all ani-
mals with similar histopathologic grade among groups
(Table 2). General comparison of the characteristics
including MIT, injury score, LA, IELa, EELa, MA, IA, RL
(%) and PI between treatment and control groups are
listed in Tables 2 and 3. Compared with the control
group, MIT in HXS is significantly reduced (P < 0.05). As
intimal hyperplasia after balloon dilation varied in pro-
portion to injury in this model [13,14], quantitative
group comparison was performed and the vessel injury
score was used as a covariance. Compared with the con-
trol group, in treatment groups HXS or LXS, RL was mark-
edly increased and PI was decreased (P < 0.05 and P < 0.01
respectively), and in HXS, LA was increased four weeks
after injury (P < 0.05).
Transmission electron microscopy
The IEL was intact in coronary artery of normal porcine.
SMCs in tunica media were a predominantly contractile
phenotype, manifested by rich myofilament in cytoplasm
Table 1: Histopathological grading
Grade Criteria
0 No injury noted
1 IEL disrupted; media compressed not lacerated
2 IEL disrupted; media visibly lacerated
3 EEL disruptedChinese Medicine 2006, 1:2 http://www.cmjournal.org/content/1/1/2
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and only few rough endoplasmic reticulum (RER), mito-
chondria and free ribosomes around the nucelus. In coro-
nary artery from mini-pigs of control group, IEL was
disrupted at location of balloon dilation and SMC trans-
migrated from media to intima. Hyperplastic SMCs'
fibroblasts and few macrophages were frequently seen in
neointima. As compared with normal animals, SMCs with
synthetic phenotype were more frequently seen in control
group, manifested by hypertrophic cell body, increased
karyoplasmic ratio, well-developed Golgi's complex,
more RER, mitochondria, free ribosomes and fewer myo-
filament in cytoplasm. Both probucol and XS0601 inhib-
ited the transition of SMC phenotype from contractile to
synthetic one, especially in HXS group, which showed less
increased organelles related to biosynthesis (Figure 2).
Immunocytochemical detection of proliferating SMCs
In HXS, administration of XS was also associated with a
reduction of the proliferative activity in the neointimal
layer, as indicated by the PCNA labelling index (4.87%
vs.10.14%, P < 0.05) (Figures 3 and 4). Although PCNA
staining measures the total cell replication activity in the
artery segment, injured arteries examined by transmission
electron microscopy showed that the proliferating intima
was composed primarily of SMCs.
Angiographic analysis
As presented in Tables 2 and 4, the arterial diameters
before and after balloon injury, the balloon-to-artery
ratios, dilation and acute gain were similar among groups.
All of the drug groups seemed to have decreased late
lumen loss and increased the arterial diameters at the
fourth week, compared to the control group, but there was
no significant difference among them (P > 0.05). Taking
acute gain as covariances, both XS0601 and probucol
markedly reduced angiographic late lumen loss (P > 0.05)
and late lumen loss resulting from intimal hyperplasia (P
< 0.01), which was similar to the results obtained with the
morphometric analysis. LXS and HXS also significantly
increased the arterial diameter at the time of follow-up (P
> 0.05) and reduced late lumen loss resulting from
remodelling (P < 0.01).
Contribution of intimal hyperplasia and remodelling to 
late loss
As shown in Table 5, the contribution of intimal thickness
or remodelling to late lumen loss was not significantly dif-
ferent among groups. From the results of the four groups,
41 ± 20% of the observed angiographic late loss could be
explained by intimal thickness, while 59 ± 20% of late
loss was due to remodelling in lumen diameter.
Representative histological cross sections of coronary arter- ies 4 weeks after balloon injury (Verhoeff-van Gieson elastin  stain, ×50) Figure 1
Representative histological cross sections of coro-
nary arteries 4 weeks after balloon injury (Verhoeff-
van Gieson elastin stain, ×50). A: Control; B: Probucol; 
C: LXS; D: HXS. Disruption of the internal elastic lamina (←) 
was similar at the site of intimal reaction in all groups. Signifi-
cant reduction of intimal hyperplasia was observed in groups 
treated with drugs, especially in HXS, compared with con-
trol.
Table 2: Baseline, angiographic and histopathological characteristics
Characteristics Control Probucol LXS HXS
M i n i - p i g 5555
Weight (kg) 32.4 ± 3.36 31 ± 2.74 32 ± 3.32 30.4 ± 2.19
Angiography
Balloon-to-artery ratio 1.40 ± 0.04 1.37 ± 0.10 1.37 ± 0.09 1.42 ± 0.06
Dilation (after injury) (%) 21.21 ± 0.06 22.24 ± 0.09 24.99 ± 0.09 23.69 ± 0.05
Histopathology
Pathological grade 2.6 ± 0.89 2.6 ± 0.89 3 ± 0 2.4 ± 0.89
Injury score 0.35 ± 0.18 0.31 ± 0.20 0.31 ± 0.11 0.41 ± 0.20
Values are mean ± SD. No value was significantly different among the four groups by ANOVA (P > 0.05).Chinese Medicine 2006, 1:2 http://www.cmjournal.org/content/1/1/2
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Representative SMC phenotype in neointima observed by transmission electron microscopy (×8000) Figure 2
Representative SMC phenotype in neointima observed by transmission electron microscopy (×8000). A: Con-
trol; B: Probucol; C: HXS; D: Normal (SMC form tunica media). SMCs of contractile phenotype obtained from tunica media of 
normal tissue have rich myofilament in cytoplasm and few organelles related to biosynthesis. However, SMCs with synthetic 
phenotype were more frequently seen in control and they have more organelles (→) related to biosynthesis and fewer myofil-
ament in cytoplasm. Both probucol and XS0601 inhibited transition of SMC phenotype from the contractile to the synthetic, 
especially in HXS where less increased organelles related to biosynthesis were found.
A B
CC D
Table 3: Morphometric analysis
Control Probucol LXS HXS
MIT (mm) 0.89 ± 0.40 0.54 ± 0.15 0.48 ± 0.08 0.34 ± 0.05*
LA (mm2) 0.90 ± 1.18 1.35 ± 0.83 1.88 ± 0.91 2.01 ± 0.88 ▲
IELa (mm2) 2.20 ± 0.65 2.16 ± 0.64 2.62 ± 1.03 2.52 ± 0.76
EELa (mm2) 3.22 ± 0.63 3.34 ± 0.62 3.68 ± 1.18 3.40 ± 0.64
MA (mm2) 1.02 ± 0.11 1.18 ± 0.43 1.06 ± 0.47 0.88 ± 0.30
IA (mm2) 1.30 ± 0.68 0.81 ± 0.68 0.74 ± 0.14 0.51 ± 0.27
RL (%) 34.00 ± 37.00 62.00 ± 24.00 ▲ 70.00 ± 7.00 ▲▲ 77.00 ± 14.00
PI 0.43 ± 0.23 0.24 ± 0.18 ▲ 0.21 ± 0.04 ▲▲ 0.16 ± 0.09 ▲▲
Values are mean ± SD. *P < 0.05, significance vs. control: comparison of group means after ANOVA; ▲  P < 0.05, ▲▲  P < 0.01, significance vs. 
control: comparison of group means after ANOVA taking injury score as covariance.Chinese Medicine 2006, 1:2 http://www.cmjournal.org/content/1/1/2
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Discussion
The pathogenesis of restenosis is not yet fully understood.
However, it is generally accepted that the main initial fac-
tors of restenosis are adhesion and aggregation of platelets
triggered by vascular injury, leading to the secretion of
some chemokines and mitogens such as platelet-derived
growth factor (PDGF) and basic fibroblast growth factor
(bFGF). These growth factors stimulate the SMC migra-
tion and proliferation [15,16], which are considered to be
pivotal to the formation of a neointimal lesion. The phe-
notype transition from the contractile to the synthetic is a
morphologic characteristic of actively hyperplastic SMCs.
The SMCs with synthetic phenotype react strongly to
growth factors, produce and secrete a large amount of
extracellular matrix (ECM), and also have capability to
migrate and transmigrate [3]. Once the SMCs were acti-
vated to change phenotypes, in addition to division
growth and ECM secretion, they could produce autocrine
or paracrine mediators such as interleukin-1, tumour
necrosis factor, PDGF and FGF. Thus, SMCs stimulate
Immunocytochemical detection of proliferating SMCs in neointima (×400) Figure 3
Immunocytochemical detection of proliferating SMCs in neointima (×400). A: Control; B: Probucol; C: LXS; D: 
HXS. There are more PCNA-positive cells (→) in neointima of injuried coronary artery in control, indicating a state of cell 
proliferation, than those in different treatment groups, especially in HXS.
AB
CD
Comparison of PCNA labelling index in neointima of injury  coronary artery among groups Figure 4
Comparison of PCNA labelling index in neointima of 
injury coronary artery among groups. In HXS, a signifi-
cant reduction of the proliferative activity in the neointimal 
layer was indicated by the PCNA labelling index (HXS 4.87% 
vs. Control 10.14%, P < 0.05).
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themselves and adjacent SMCs to proliferate and form
hyperplasia [17]. An investigation showed that the vol-
ume index of synthetic organelle of SMCs in lesions from
restenosis patients after PTCA was much more than those
in de novo lesions, which indicated that a great quantity of
SMCs were transforming from contractile to synthetic
phenotype during the process of restenosis formation [3].
In the present study, obviously thickened neointima was
formed after PTCA in this porcine coronary injury model.
PCNA-positive cells were highly expressed in neointima
and they were reduced significantly in HXS group. This
reduction indicated that coronary injury caused prolifera-
tion of intimal cells and XS0601 had inhibitory effect on
cell multiplication. Results from electron microscopy fur-
ther demonstrated that SMCs were the most frequently
seen cell type in neointima, and that SMCs with synthetic
phenotype increased remarkably in neointima in control
group. All of the treatment groups could reduce the pro-
portion of SMCs with synthetic phenotype to different
extent, especially in HXS group. The results indicated a
possible mechanism in preventing restenosis that XS0601
could inhibit the proliferation of SMCs and their pheno-
type transformation in neointima after coronary balloon
injury, and thus reduce intimal hyperplasia.
Recently, vascular remodelling, defined as a structural
change in total arterial circumference during the resteno-
sis formation period, is recognized as a major cause of the
restenosis [18]. The results from other research groups on
different arteries, interventions, species and experimental
conditions [6,7] consistently showed that intimal hyper-
plasia accounts for only a minor proportion of the angio-
graphic late loss in lumen diameter. In our angiographic
and histologic study of the Chinese mini-pig fed with nor-
molipemic diet, remodelling accounted for 59% of late
lumen loss, and intimal hyperplasia, 41%. Both intimal
hyperplasia and vascular remodelling were attributed to
late lumen loss in this porcine coronary injury model. Sev-
eral agents showed potent inhibitory effects on intimal
hyperplasia in experimental studies. However, few of
them demonstrated their use in preventing restenosis in
clinical trials [2]. In our view, arterial remodelling should
be considered as a novel therapeutic target, in view of its
importance in the development of restenosis. It is
accepted that stents reduce restenosis, by improving the
initial angiographic result and by withstanding the late
pathologic remodelling forces that lead to restenosis after
other types of interventions [2]. In addition, all-trans-reti-
notic acid (derivatives of vitamin A), PP1 (a dual inhibitor
of PDGF beta-receptor and Src kinase activity), soluble
TGF-betaRII, probucol and endovascular beta-radiation
therapy also showed effects on pathologic remodelling in
experimental or clinical studies [19-24]. In this study,
XS0601 has also shown potential effects on preventing
late lumen loss resulting from vascular remodelling.
Since the process of restenosis is involved in multiple
pathogenic processes, such as adhesion and aggregation
of platelets, thrombosis, migration and proliferation of
SMCs, accumulation of collagen, and remodelling. The
treatment aiming at only one target may not be enough.
Table 5: Effect of intimal thickness or remodelling on late lumen loss
Control Probucol LXS HXS Combined
Late loss (mm) 1.32 ± 0.71 0.74 ± 0.39 ▲▲ 0.78 ± 0.33 ▲▲ 0.59 ± 0.28 ▲▲
Mean intimal thickness × 2 (mm) 0.71 ± 0.42 0.35 ± 0.29 ▲ 0.28 ± 0.03 ▲▲ 0.21 ± 0.12 ▲▲
Discrepancy (remodelling) 0.60 ± 0.39 0.39 ± 0.22 0.50 ± 0.31 ▲ 0.37 ± 0.23 ▲▲
Contribution of thickness (%) 51 ± 15 42 ± 19 44 ± 27 35 ± 19 41 ± 20
Contribution of remodelling (%) 49 ± 15 58 ± 19 56 ± 27 65 ± 19 59 ± 20
Values are mean ± SD. No values were significantly different between groups by ANOVA (P > 0.05). P < 0.05,
Table 4: Angiographic analysis
Control Probucol LXS HXS
Diameter (before, mm) 2.20 ± 0.33 2.05 ± 0.33 2.22 ± 0.49 2.12 ± 0.34
Diameter (after, mm) 2.66 ± 0.34 2.49 ± 0.30 2.75 ± 0.47 2.62 ± 0.45
Diameter (follow-up, mm) 1.34 ± 0.82 1.75 ± 0.47 1.97 ± 0.51 ▲ 2.03 ± 0.30 ▲
Acute gain(mm) 0.43 ± 0.17 0.51 ± 0.10 0.58 ± 0.03 0.55 ± 0.11
Late loss (mm) 1.32 ± 0.71 0.74 ± 0.39 ▲▲ 0.78 ± 0.33 ▲▲ 0.59 ± 0.28 ▲▲
Values are mean ± SD. No values were significantly different between groups by ANOVA (P > 0.05). ▲  P < 0.05, ▲▲  P < 0.01, significance vs. 
control: comparison of group means after ANOVA taking acute gain as covariance.Chinese Medicine 2006, 1:2 http://www.cmjournal.org/content/1/1/2
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The failure of numerous agents for preventing restenosis
also suggests the limitation of drugs with only one thera-
peutic target. Chinese herbal medicines consisting of mul-
tiple active components might treat diseases with
integrating function on multiple targets. XS0601 consists
of the main active factions of Ligusticum chuanxiong Hort.
and Paeonia lactiflora Pall, which are the most commonly
used Chinese herbs to improve blood circulation. It has
already been demonstrated that the prescriptions for
improving blood circulation may regulate blood lipid lev-
els, inhibit the proliferation of SMCs and the activation of
platelets, and protect endothelial cells from injury and
inhibit lipid peroxidation [25]. Thus XS0601 may prevent
restenosis through multiple pathways, which need to be
elucidated by further studies.
Conclusion
The present study found that both intimal hyperplasia
and vascular remodelling are attributed to late lumen loss
in this porcine coronary injury model. XS0601 markedly
reduced angiographic late lumen loss resulting from vas-
cular remodelling. These findings suggest that XS0601
may be useful to prevent restenosis.
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